SCHEMBL4551274

SCHEMBL4551274

CCc1ccc(Br)cc1C1OC1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.38
TSHR P16473 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
EDNRB P24530 2/20 0.36
EDNRA P25101 2/20 0.36
TP53 P04637 3/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 2/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
MAPK1 P28482 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL406454 0.71 TSHR (0.41) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL2122975 0.70 ALDH1A1 (0.38) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL404243 0.70 TSHR (0.40) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL7787482 0.69 GABRA1 (0.44) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL407762 0.69 MAPK1 (0.36) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL2121466 0.69 MAPK1 (0.36) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL410941 0.69 LMNA (0.38) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL3027915 0.68 TSHR (0.38) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL418249 0.68 LMNA (0.38) LMNATSHRSMN1; SMN2HPGDL3MBTL1
SCHEMBL882732 0.68 PYCR1 (0.47) LMNATSHRSMN1; SMN2HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054315-A1 CATHEPSIN S INHIBITOR COMPOUNDS ELI LILLY AND COMPANY (US) 2012-04-26 WO disclosed